16:09 EST Taysha Gene Therapies (TSHA) files $300M mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TSHA:
- Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
- Taysha Gene Therapies price target raised to $8 from $6 at Canaccord
- 3 Best Stocks to Buy Now, 11/14/2024, According to Top Analysts
- Taysha Gene Therapies Advances in Rett Syndrome Trials
- Taysha Gene Therapies reports Q3 EPS (10c), consensus (9c)